1. Soulières, Denis, Hirsch, Fred R, Shepherd, Frances A, Shames, David S, Klughammer, Barbara. . PTPRF Expression as a Potential Prognostic/Predictive Marker for Treatment with Erlotinib in Non-Small-Cell Lung Cancer. In Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 10, 1364-1369. doi:10.1097/JTO.0000000000000624. https://pubmed.ncbi.nlm.nih.gov/26291013/
2. Ausavarat, Surasawadee, Tongkobpetch, Siraprapa, Praphanphoj, Verayuth, Suphapeetiporn, Kanya, Shotelersuk, Vorasuk. 2011. PTPRF is disrupted in a patient with syndromic amastia. In BMC medical genetics, 12, 46. doi:10.1186/1471-2350-12-46. https://pubmed.ncbi.nlm.nih.gov/21453473/
3. Borck, Guntram, de Vries, Liat, Wu, Hsin-Jung, Kubisch, Christian, Basel-Vanagaite, Lina. 2014. Homozygous truncating PTPRF mutation causes athelia. In Human genetics, 133, 1041-7. doi:10.1007/s00439-014-1445-1. https://pubmed.ncbi.nlm.nih.gov/24781087/
4. Wang, Jiankui, Ma, Yuhao, Li, Tun, Wu, Keliang, Deng, Xuemei. 2023. MiR-199a-3p Regulates the PTPRF/β-Catenin Axis in Hair Follicle Development: Insights into the Pathogenic Mechanism of Alopecia Areata. In International journal of molecular sciences, 24, . doi:10.3390/ijms242417632. https://pubmed.ncbi.nlm.nih.gov/38139460/